Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study.
Saved in:
| Title: | Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study. |
|---|---|
| Authors: | Lee JY; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea., Choi S; Division of Data Science, PIPET, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Jung S; Division of Data Science, PIPET, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Park SS; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Kim JS; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea., Shin SH; Department of Hematology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Jeon YW; Department of Hematology, Yeoido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Yahng SA; Department of Hematology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Republic of Korea., Kim HJ; Department of Hematology-Oncology, Hallym University Medical Center, Hallym University College of Medicine, Anyang, Republic of Korea., Lee GW; Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea., Eom HS; Department of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang, Republic of Korea., Kim MK; Division of Hemato-Oncology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Republic of Korea., Kim Y; Division of Hemato-Oncology, Department of Internal Medicine, Wonju Severance Christian Hospital, Wonju, Republic of Korea., Kwon J; Department of Internal Medicine, Hematology and Oncology, College of Medicine, Chungbuk National University, Cheongju, Republic of Korea., Min CK; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. ckmin@catholic.ac.kr. |
| Corporate Authors: | Korean Multiple Myeloma Working Party (KMMWP) |
| Source: | Annals of hematology [Ann Hematol] 2026 Mar 23; Vol. 105 (4). Date of Electronic Publication: 2026 Mar 23. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41866558 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lee+JY%22">Lee JY</searchLink>; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Choi+S%22">Choi S</searchLink>; Division of Data Science, PIPET, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jung+S%22">Jung S</searchLink>; Division of Data Science, PIPET, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Department of Pharmacology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+SS%22">Park SS</searchLink>; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JS%22">Kim JS</searchLink>; Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shin+SH%22">Shin SH</searchLink>; Department of Hematology, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jeon+YW%22">Jeon YW</searchLink>; Department of Hematology, Yeoido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yahng+SA%22">Yahng SA</searchLink>; Department of Hematology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JJ%22">Lee JJ</searchLink>; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+HJ%22">Kim HJ</searchLink>; Department of Hematology-Oncology, Hallym University Medical Center, Hallym University College of Medicine, Anyang, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+GW%22">Lee GW</searchLink>; Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Eom+HS%22">Eom HS</searchLink>; Department of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+MK%22">Kim MK</searchLink>; Division of Hemato-Oncology, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+Y%22">Kim Y</searchLink>; Division of Hemato-Oncology, Department of Internal Medicine, Wonju Severance Christian Hospital, Wonju, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kwon+J%22">Kwon J</searchLink>; Department of Internal Medicine, Hematology and Oncology, College of Medicine, Chungbuk National University, Cheongju, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Min+CK%22">Min CK</searchLink>; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. ckmin@catholic.ac.kr. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22Korean+Multiple+Myeloma+Working+Party+%28KMMWP%29%22">Korean Multiple Myeloma Working Party (KMMWP)</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2026 Mar 23; Vol. 105 (4). <i>Date of Electronic Publication: </i>2026 Mar 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41866558 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00277-026-06849-w Languages: – Code: eng Text: English Titles: – TitleFull: Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lee JY – PersonEntity: Name: NameFull: Choi S – PersonEntity: Name: NameFull: Jung S – PersonEntity: Name: NameFull: Park SS – PersonEntity: Name: NameFull: Kim JS – PersonEntity: Name: NameFull: Shin SH – PersonEntity: Name: NameFull: Jeon YW – PersonEntity: Name: NameFull: Yahng SA – PersonEntity: Name: NameFull: Lee JJ – PersonEntity: Name: NameFull: Kim HJ – PersonEntity: Name: NameFull: Lee GW – PersonEntity: Name: NameFull: Eom HS – PersonEntity: Name: NameFull: Kim MK – PersonEntity: Name: NameFull: Kim Y – PersonEntity: Name: NameFull: Kwon J – PersonEntity: Name: NameFull: Min CK IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 03 Text: 2026 Mar 23 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-0584 Numbering: – Type: volume Value: 105 – Type: issue Value: 4 Titles: – TitleFull: Annals of hematology Type: main |
| ResultId | 1 |